Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. 🌟📚💉🔬🧬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. 📚💉🔬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. 🏆🔬🎓

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 📚. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics 🧪. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education 💡. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences 🎓.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. 📚💊🐾👩‍🔬👨‍🔬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. 🔬💉🧬🫀

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated γ/δ T cell maturation of dendritic cells

 

 

Muhammad Usama Mazhar | Biology and Life Sciences | Best Researcher Award

Muhammad Usama Mazhar | Biology and Life Sciences | Best Researcher Award

Dr Muhammad Usama Mazhar, Quaid I Azam University, Pakistan

Based on Dr. Muhammad Usama Mazhar’s comprehensive profile and achievements, he appears to be a strong candidate for the Best Researcher Award. Here’s a breakdown of his qualifications and contributions:

Publication profile

google scholar

Professional Experience

Dr. Mazhar has accumulated extensive teaching experience over nearly five years, including roles as a visiting lab instructor at Quaid-i-Azam University and as a lecturer at various institutions. His experience spans both academic and clinical settings, showcasing his versatility and commitment to education.

Honors and Awards

Dr. Mazhar has consistently demonstrated academic excellence, reflected in multiple scholarships and awards throughout his Pharm.D. and M.Phil. studies. His recognition as the Best Teacher of the Session 2015-16 highlights his effective teaching and impact on students.

Educational Background

Dr. Mazhar’s educational credentials include a Ph.D. in Pharmacology (thesis submitted) and an M.Phil. in Pharmacology, both from reputable institutions. His strong academic foundation supports his research capabilities.

Research Contributions

Dr. Mazhar has published several significant research papers, including studies on the spasmolytic effects of Astragalus sarcocolla, chronic stress and neuroinflammation, and the pharmacokinetics of Rasagiline. His research spans diverse topics such as pharmacology, neurobiology, and therapeutic potentials, indicating a broad and impactful research agenda.

Workshops and Conferences

His participation in various workshops and international conferences demonstrates his commitment to staying updated with global trends and contributing to scientific discussions.

Teaching and Mentorship

His teaching experience at various esteemed institutions, including the Indian Institute of Information Technology Design and Manufacturing and National Institute of Technology, reflects his commitment to education and mentorship in his field.

Summary

Dr. Muhammad Usama Mazhar’s impressive combination of teaching experience, academic awards, rigorous educational background, impactful research publications, and active participation in professional development makes him a suitable candidate for the Best Researcher Award. His research not only advances pharmacological knowledge but also addresses significant clinical and therapeutic challenges.

Publication top notes

The spasmolytic effect of astragalus sarcocolla on the intestinal smooth muscles of rabbit in vitro: Potassium channel opening

Chronic stress intensify PTZ-induced seizures by triggering neuroinflammation and oxidative stress

Immunostimulant, hepatoprotective, and nephroprotective potential of Bacillus subtilis (NMCC-path-14) in comparison to dexamethasone in alleviating CFA-induced arthritis

Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses

In-vitro anticoagulant activity of three extracts of Astragalus sarcocolla

Anti-inflammatory and anti-arthritic potential of Coagulansin-A: in vitro and in vivo studies

Antiplatelet and Anticoagulant Activities of Astragalus sarcocolla Dymock

In vivo evaluation of efficacy and safety of Coagulansin-A in treating arthritis

Iwona Golonka | Biology and Life Sciences | Hypothesis Achievement Award

Iwona Golonka | Biology and Life Sciences | Hypothesis Achievement Award

Dr Iwona Golonka, Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland

Iwona Maria Golonka is an assistant professor at Wroclaw Medical University, specializing in Physical Chemistry and Biophysics. She earned her Ph.D. in Chemical Sciences from the University of Wrocław and holds a Master’s degree in Chemistry. With over 15 impactful publications and a research focus on antimicrobial peptides and advanced pharmaceutical methods, her work includes significant national and international collaborations. Notable achievements include awards for her research in antimicrobial compounds and patents for innovative drug delivery methods. She has also contributed to academic lectures and conferences globally. 🧪📚🏅

Publication profile

Orcid

Education

Dr. Iwona Golonka has been an Assistant Professor at Wroclaw Medical University’s Faculty of Pharmacy since 2003, specializing in Physical Chemistry and Biophysics. With 15 scientific papers boasting a total Impact Factor of 48.378, including a notable 2020 publication with an IF of 9.381, Dr. [Name] has significantly contributed to the field. They also co-authored a script for pharmacy and medical analytics students. Dr. [Name] earned their Ph.D. in Chemical Sciences from the University of Wrocław in 2006, with a focus on coordination chemistry, following a Master’s degree in Chemistry in 1999. 🧪📚🔬

Presentations

Golonka I. has contributed significantly to the field of chemistry through various presentations. At the Chemistry towards Biology 10 conference in Bratislava (2022), she explored peptide stability in monolayers and Langmuir balance applications in pharmaceutical sciences. Earlier, at the Fifth Informal Conference on Reaction Kinetics and Atmosphere Chemistry (2004), she studied the reactions of nitrogen dioxide with propanols and fluorinated derivatives. Her research on EPR characteristics of metal complexes was presented at the 9th Nordic IHSS Symposium (2003), and she investigated the impact of metal ions on free radicals in humic brown coal at ISEB 15 (2001). 🌟🔬📊

Awards

In 2022, the Rector of the Medical University of Gdańsk awarded a diploma for scientific and team achievements of the 1st degree for the synthesis and assessment of new antimicrobial compounds and fluorescent dyes. Individual awards of II degree were received in 2021, 2020, and 2022 for publications in the JCR database. In 2016, received a 1st degree Team Award for work on physicochemical methods in drug development and a distinction in the Eureka! MZD competition for inventing a flotation tablet. Previous accolades include the 2004 Dr. Emil Niedźwirski Scholarship and multiple team awards in 2007, 2010, and 2016. 🏆📜🔬💡

Research focus

Iwona Golonka’s research focuses on the stability and effectiveness of peptides and antioxidants in various matrices. Her work includes evaluating the decay kinetics of antioxidants in black elderberry, studying the impact of peptides on monolayers, and analyzing peptide stability. Key studies involve examining how newly synthesized peptides affect monolayer stability and antibacterial properties. Golonka’s contributions also cover antioxidant properties in cellulose matrices and interactions with phosphatidylinositol monolayers. Her research integrates aspects of biochemistry and material science, aiming to enhance the understanding and application of peptides and antioxidants in health and industry. 🧬🔬🍇

Publication top notes

Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers

Evaluation of the Effect of Antibacterial Peptides on Model Monolayers

Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed

Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative

Antimicrobial and Antioxidative Activity of Newly Synthesized Peptides Absorbed into Bacterial Cellulose Carrier against Acne vulgaris

Edible alginate/chitosan-based nanocomposite microspheres as delivery vehicles of omega-3 rich oils

The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin

Antioxidant and antibacterial activities of omega-3 rich oils/curcumin nanoemulsions loaded in chitosan and alginate-based microbeads

Application of an anionic polymer in the formulation of floating tablets containing an alkaline model drug

Selected physicochemical and biological properties of ethyl ascorbic acid compared to ascorbic acid

Zoia Arshad Awan | Biology and Life Sciences | Best Researcher Award

Zoia Arshad Awan | Biology and Life Sciences | Best Researcher Award

Dr Zoia Arshad Awan, Teagasc, Food Research Centre, Ashtown. Ireland

Zoia Arshad Awan is a seasoned researcher specializing in plant pathology and horticulture. 🌿 With a Ph.D. from the University of the Punjab, she has significantly contributed to studies on biocontrol of plant pathogens and the improvement of crop productivity. 🌾 As a Research Officer at Teagasc Ashtown Food Research Centre, she leads innovative projects in vertical farming and hydroponics. Previously, she provided technical insights at WWF-Pakistan and contributed to various research roles at the University of the Punjab and The University of Queensland. 🌍 Her extensive publication record includes impactful research in plant disease management and agricultural sustainability. 📚

Publication profile

google scholar

Education

Dr. Zoia Arshad Awan earned a Ph.D. in Agricultural Sciences (Plant Pathology) from the Faculty of Agricultural Sciences, University of the Punjab, Pakistan, with a 3.76/4.00 CGPA. Their thesis focused on the “Antifungal Potential of Bacterial Bioactive Products and Plant Nutrients in Managing Early Blight Disease of Tomato.” They completed their M.Sc. (Hons.) in Agriculture Plant Pathology with a 3.93/4.00 CGPA, researching “A Polyphasic Approach to the Identification of Aspergillus Section Flavi.” Their B.Sc. (Hons.) in the same field had a 3.51/4.00 CGPA, with a report on “Isolation, Purification, and Identification of Phyto-pathogenic Bacteria and Fungi from Guava Orchards.” 🌱🔬📚

Experience

Dr. Zoia Arshad Awan🌿 is a dedicated researcher with extensive experience in horticulture and sustainable agriculture. Currently serving as a Research Officer at Teagasc Ashtown Food Research Centre in Dublin, Ireland (02/2023-09/2024), they focus on designing and managing research in protected and semi-protected horticulture. Previously, they worked at WWF-Pakistan (08/2020-02/2023), providing technical inputs and building field research capacity. They also contributed as a Research Assistant at the University of the Punjab, Pakistan (10/2015-02/2020), and gained international experience as a Visiting Researcher at The University of Queensland, Australia (12/2019-10/2019). Their early career includes roles at the First Fungal Culture Bank of Pakistan and as a Research Intern at WMTI, Lahore. 🌱📈

Awards

Awarded the International Research Support Initiative Program (IRSIP) scholarship by the Higher Education Commission (HEC), Pakistan, during Ph.D. studies 🎓. Received the prestigious Doctoral Programme Coordination Committee (DPCC) merit scholarship from the University of Punjab, Lahore, Pakistan 🏅. Completed an MPhil degree with distinction, showcasing exceptional academic performance 🌟. Earned internal merit scholarships during M.Sc. (Hons.) and B.Sc. (Hons.), highlighting a consistent record of excellence and dedication to academic achievements 📚.

Research focus

Based on the listed publications, the research focus of A Shoaib revolves around plant pathology, specifically in developing resistance strategies for tomato plants against early blight disease. The studies explore various approaches such as using antagonistic bacteria, Bacillus subtilis, and different fertilizers to induce disease resistance. Additionally, Shoaib investigates the biochemical and physiological responses of plants to stressors like heavy metals and pathogens, including the role of antioxidant enzymes and exogenous compounds. This research contributes to improving plant health and disease management in agricultural settings. 🌱🦠🔬

Publication top notes

Variations in total phenolics and antioxidant enzymes cause phenotypic variability and differential resistant response in tomato genotypes against early blight disease

Intervention of antagonistic bacteria as a potential inducer of disease resistance in tomato to mitigate early blight

Combating early blight infection by employing Bacillus subtilis in combination with plant fertilizers

Crosstalk of Zn in combination with other fertilizers underpins interactive effects and induces resistance in tomato plant against early blight disease

Macrophomina phaseolina alters the biochemical pathway in Vigna radiata chastened by Zn2+ and FYM to improve plant growth

Exogenous melatonin alleviates cadmium-induced inhibition of growth and photosynthesis through upregulating antioxidant defense system in strawberry

Anti-mycotic potential of Trichoderma spp. and leaf biomass of Azadirachta indica against the charcoal rot pathogen, Macrophomina phaseolina (Tassi) Goid in …

Chromium tolerance, oxidative stress response, morphological characteristics, and FTIR studies of phytopathogenic fungus Sclerotium rolfsii

Contending charcoal rot disease of mungbean by employing biocontrol Ochrobactrum ciceri and zinc

Antifungal potential of volatiles produced by Bacillus subtilis BS-01 against Alternaria solani in Solanum lycopersicum

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Prof Andrei Kozlov, Vavilov Institute of General Genetics RAS, Russia

Prof. Andrei Kozlov is the Chief of the Lab of Gene Neofunctionalization at the Vavilov Institute of General Genetics RAS and the Director of The Biomedical Center in St. Petersburg, Russia. He also heads the Kozlov Laboratory of Theoretical Biology at Peter the Great St. Petersburg Polytechnic University. Born on May 22, 1950, in St. Petersburg, he earned his M.Sci. in Biochemistry from Leningrad State University and his Ph.D. from the Petrov Research Institute of Oncology. With extensive research in molecular virology and oncology, he has significantly contributed to HIV and cancer research. Prof. Kozlov is married with three children. 📚🔬👨‍👩‍👧‍👦

Publication profile

scopus

Education

In 1972, I earned my M.Sci. in Biochemistry from the Chair of Biochemistry at Leningrad State University, Leningrad, Russia. 🧬 From 1972 to 1975, I pursued my Ph.D. at the Petrov Research Institute of Oncology in St. Petersburg, Russia, focusing on the biochemistry of nucleic acids in both normal and malignant tissues. My Ph.D. thesis was titled “A comparative study of low molecular weight nuclear RNAs in normal and tumor tissues.” 📚 Between 1978 and 1979, I underwent postdoctoral research training in the Lab of Tumor Cell Biology under Dr. R. C. Gallo at the NCI, NIH, Bethesda, MD, USA, specializing in molecular oncovirology. 🔬

Experience

In 1981, I began my career as a Molecular Biology Lecturer at the prestigious Boarding School №45 for especially talented children, attached to St. Petersburg State University. From 1983 to 1987, I lectured on the Biochemistry of nucleic acids at the university’s Department of Biochemistry. I founded and served as Deputy Director of the MPH Program at St. Petersburg State University from 2005 to 2012, where I also lectured on HIV/AIDS Epidemiology & Prevention. Since 2012, I’ve been the Founder and Chief of the St. Petersburg Seminar on Molecular and Evolutionary Biology. Between 2018 and 2019, I was a Professor in the Department of Medical Physics at Peter the Great St. Petersburg Polytechnic University, and since 2019, I have served as a High School Professor at the Institute of Biomedical Systems and Biotechnology. 🌟📚

Honors

From 1992 to 2010, a Fellowship at the International Agency for Research on Cancer (IARC) was the foundation for many notable achievements. During this time, the annual international conference “AIDS, Cancer and Public Health” was established, and 19 conferences were chaired. Notable positions included advisory roles to the Russian parliament on HIV legislation (1994-1995), coordination of the Russian HIV Vaccine Project (1998-2002), and serving on various advisory boards. Numerous awards were received, such as the Russian National Chumakov Award (1999) and the Vernadsky Award (2005). The Vavilov Prize (2020) recognized contributions to cancer and HIV research. 🧬🏅🌍

Research focus

It seems you’re interested in the research focus of A.P. Kozlov. Based on the list of publications provided, Kozlov’s research primarily revolves around the evolutionary and developmental biology (evo-devo) of gene expression, the role of tumors in evolution, and the relationship between normal and tumor-like organs. Kozlov’s work integrates aspects of molecular evolution, gene expression patterns in cancer, and the emergence of novel cell types during evolution. Notably, Kozlov explores the theory of “carcino-evo-devo,” which posits a significant evolutionary role for hereditary tumors. This interdisciplinary approach spans genomics, oncology, and evolutionary biology, shedding light on the complexity of developmental processes and cancer evolution. 🧬🔬🦠📊

Publication top notes

Diagrams Describing the Evolution of Gene Expression, the Emergence of Novel Cell Types During Evolution, and Evo-devo

Carcino-Evo-Devo, A Theory of the Evolutionary Role of Hereditary Tumors

The Theory of Carcino-Evo-Devo and Its Non-Trivial Predictions

Mammalian tumor-like organs. 2. Mammalian adipose has many tumor features and obesity is a tumor-like process

Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development

Biological Computation and Compatibility Search in the Possibility Space as the Mechanism of Complexity Increase During Progressive Evolution

Erratum: Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans (Infectious Agents and Cancer (2019) 14 (46) DOI: 10.1186/s13027-019-0262-5)

Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans

Oncogenes, tumor suppressor and differentiation genes represent the oldest human gene classes and evolve concurrently

The increase of the magnitude of spontaneous viral blips in some participants of phase II clinical trial of therapeutic optimized HIV DNA vaccine candidate